Literature DB >> 6322375

Lung angiotensin converting enzyme activity in monocrotaline pulmonary hypertension.

P M Keane, J M Kay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6322375      PMCID： PMC459746          DOI： 10.1136/thx.39.2.159

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  2 in total

1.  Changes in angiotensin-converting enzyme activity in lungs damaged by the pyrrolizidine alkaloid monocrotaline.

Authors:  W M Lafranconi; R J Huxtable
Journal:  Thorax       Date:  1983-04       Impact factor: 9.139

2.  The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium.

Authors:  R Huxtable; D Ciaramitaro; D Eisenstein
Journal:  Mol Pharmacol       Date:  1978-11       Impact factor: 4.436
  2 in total
  2 in total

1.  Effect of monocrotaline ingestion on the distribution of protein and angiotensin converting enzyme activity in the rat lung.

Authors:  D J Shale; M S Wiseman; W O Cookson
Journal:  Thorax       Date:  1986-12       Impact factor: 9.139

2.  Monocrotaline pyrrole-induced changes in angiotensin-converting enzyme activity of cultured pulmonary artery endothelial cells.

Authors:  C M Hoorn; R A Roth
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.